NPPA computed the Retail Price of Relugolix 40 mg + Estradiol Hemihydrate USP equivalents to Estradiol 1 mg + Norethindrone Acetate USP 0.5 mg for M/s Macmillon Pharmaceuticals Pvt. Ltd. (Manufacturer) & M/s Jagsonpal Pharmaceuticals Ltd. (Marketer)

Apr 09, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific Compliance

The National Pharmaceutical Pricing Authority (NPPA) on April 06, 2026, issued the Computation of Retail Price of Relugolix 40 mg + Estradiol Hemihydrate USP equivalents to Estradiol 1 mg + Norethindrone Acetate USP 0.5 mg for M/s Macmillon Pharmaceuticals Pvt. Ltd. (Manufacturer) & M/s Jagsonpal Pharmaceuticals Ltd. (Marketer).

The following has been stated namely: -

• The Retail Price has been computed for Each Film Coated Tablet Containing Relugolix 40 mg + Estradiol Hemihydrate USP equivalents to Estradiol 1 mg + Norethindrone Acetate USP 0.5 mg for M/s Macmillon Pharmaceuticals Pvt. Ltd. (Manufacturer) & M/s Jagsonpal Pharmaceuticals Ltd. (Marketer)

• Proposed Price (Lower of worked out price and Claimed price) is 107.22

[Notification No. 19(5039)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT